Status:
RECRUITING
Observational Study in Localized Osteosarcoma
Lead Sponsor:
Italian Sarcoma Group
Collaborating Sponsors:
Associazione Italiana Ematologia Oncologia Pediatrica
Conditions:
Localized Osteosarcoma
Eligibility:
All Genders
Up to 40 years
Brief Summary
Observational prospective trial aimed to collect the collect demographic, clinical, surgical, pathological and molecular characteristics and treatment from patients affected by localized OsteoSarcoma ...
Detailed Description
Osteosarcoma is the most frequent primary malignant bone tumor in children and adolescents and is considered a rare disease. The overall incidence of OS is 0.2-3 / 100,000 inhabitants per year with a...
Eligibility Criteria
Inclusion
- Diagnosis of high grade OS of the extremities
- Age at diagnosis ≤ 40 years at the time of diagnosis
- Localized disease (skip metastases are allowed)
- Adequate organ function according the AIEOP/ISG OS 2021 recommendation
- Patients or parents oe guardians of minors who have given their written informed consent to participate in the study
Exclusion
- Presence of metastases
- Diagnosis of periosteal OS, of parosteal OS or secondary OS
- Any medical condition which can not allowed the use of the treatments recommended by AIEOP/ISG OS 2021
Key Trial Info
Start Date :
July 30 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2026
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04890067
Start Date
July 30 2021
End Date
December 30 2026
Last Update
March 10 2025
Active Locations (16)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro di Riferimento Oncologico - Unit of Medical Oncology
Aviano, Pordenone, Italy, 33081
2
Sandra Aliberti
Candiolo, Torino, Italy, 10060
3
IRCCS materno infantile Burlo Garofolo
Trieste, T, Italy, 34137
4
Azienda Ospedaliero Universitaria Consorziale Policlinico - Bari
Bari, Italy, 70124